| Literature DB >> 6674370 |
O W Prozesky, C E Stevens, W Szmuness, H Rolka, E J Harley, M C Kew, J E Scholtz, A D Mitchell.
Abstract
Three injections of 10 microgram/ml hepatitis B vaccine (Merck) given in the first week after birth, a month later and again at the age of six months to 63 neonates in a rural African population, elicited an antibody response in 93 per cent. The initial hepatitis B marker status of the babies and mothers did not influence the results at nine months. Side-effects were minor and we conclude that the vaccine can effectively and safely be used from birth in endemic situations.Entities:
Mesh：
Substances：
Year: 1983 PMID： 6674370 DOI： 10.1016/s0163-4453(83)96649-5
Source DB: PubMed Journal: J Infect ISSN： 0163-4453 Impact factor: 6.072